Migraine with aura

光环 皮质扩散性抑郁症 先兆偏头痛 心理学 偏头痛 医学 冲程(发动机) 精神科 机械工程 工程类
作者
Christian Lucas
出处
期刊:Revue Neurologique [Elsevier]
卷期号:177 (7): 779-784 被引量:49
标识
DOI:10.1016/j.neurol.2021.07.010
摘要

Around 15% to one-third of migraineurs experience aura. Aura is a fully reversible focal neurological phenomenon involving visual, sensory, speech, and/or motor symptoms that develops gradually and usually precedes the headache phase. The pivotal role of cortical spreading depression (CSD) as a mechanism underlying aura has been widely supported by a large body of studies. The diagnosis is based on the International Headache Classification Disorders III edition criteria. Aura is characterized by gradual development, duration of each symptom no longer than one hour, a mix of positive and negative features, and complete reversibility. Visual aura is the most common type of aura, occurring in over 90% of patients. When aura symptoms are multiple, they usually follow one another in succession, beginning with visual, then sensory, then aphasic; but the reverse and other orders have been noted. The accepted duration for most aura symptoms is one hour, but motor symptoms, which are rare, are often longer lasting. When a patient experiences for the first time a possible aura phase it's sometimes difficult to know if there was gradual or brutal onset of the symptoms. If the patient has no visual aura symptoms or simultaneous neurological symptoms, or presents neurological symptoms corresponding to a cerebral vascular territory, emergency exploration of a possible transient ischemic attack is necessary. Long duration (greater than one hour) of what may or may not be an aura phase, late onset of aura, or a dramatic increase in aura attacks should also be explored. The relative risk of ischemic stroke is significantly increased in migraine with aura. Combined hormonal contraception with estrogens significantly increases the risk of stroke in women with migraine with aura. It is recommended to start non-steroidal anti-inflammatory drugs (NSAIDs) or aspirin as soon as possible during the aura phase, not to treat the aura, but to avoid or to diminish the headache phase. In case of failure of NSAIDs or aspirin it is recommended to use a triptan when the headache begins. The prophylactic treatments for migraine with aura are those used in migraine without aura based on very few randomized clinical trials specifically dedicated to migraine with aura.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
酷酷的友灵完成签到,获得积分10
刚刚
鱼羊明完成签到 ,获得积分10
1秒前
andrele发布了新的文献求助150
1秒前
2秒前
铁甲小杨发布了新的文献求助10
2秒前
ouo完成签到,获得积分10
3秒前
3秒前
Akim应助刘奎冉采纳,获得10
4秒前
5秒前
EadonChen发布了新的文献求助10
5秒前
5秒前
Sun完成签到,获得积分10
5秒前
伶俐的雅寒完成签到,获得积分10
5秒前
5秒前
隐形曼青应助刘世敏采纳,获得10
5秒前
5秒前
明亮山水发布了新的文献求助200
6秒前
8秒前
聂非非完成签到,获得积分10
9秒前
aaa发布了新的文献求助10
10秒前
jason0023完成签到,获得积分10
10秒前
11秒前
澎湃完成签到,获得积分10
11秒前
lw777发布了新的文献求助10
11秒前
传奇3应助喝喂辉采纳,获得10
12秒前
13秒前
13秒前
量子星尘发布了新的文献求助10
14秒前
14秒前
完美世界应助务实的听筠采纳,获得10
15秒前
15秒前
wenhui完成签到,获得积分10
16秒前
alc完成签到,获得积分10
16秒前
吴钰婷发布了新的文献求助10
16秒前
搜集达人应助陈源采纳,获得10
17秒前
花陵发布了新的文献求助10
17秒前
17秒前
Gxt完成签到,获得积分10
17秒前
18秒前
高分求助中
2025-2031全球及中国金刚石触媒粉行业研究及十五五规划分析报告 40000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Introduction to strong mixing conditions volume 1-3 5000
Agyptische Geschichte der 21.30. Dynastie 3000
Les Mantodea de guyane 2000
„Semitische Wissenschaften“? 1510
从k到英国情人 1500
热门求助领域 (近24小时)
化学 材料科学 生物 医学 工程类 计算机科学 有机化学 物理 生物化学 纳米技术 复合材料 内科学 化学工程 人工智能 催化作用 遗传学 数学 基因 量子力学 物理化学
热门帖子
关注 科研通微信公众号,转发送积分 5753151
求助须知:如何正确求助?哪些是违规求助? 5478501
关于积分的说明 15376312
捐赠科研通 4891980
什么是DOI,文献DOI怎么找? 2630852
邀请新用户注册赠送积分活动 1579030
关于科研通互助平台的介绍 1534873